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The common occurrence of renal disease in Australian Aboriginal populations such as
Tiwi Islanders may be determined by environmental and genetic factors. To explore
genetic contributions, we performed a genome-wide association study (GWAS) of
urinary albumin creatinine ratio (ACR) in a sample of 249 Tiwi individuals with genotype
data from a 370K Affymetrix single nucleotide polymorphism (SNP) array. A principal
component analysis (PCA) of the 249 individual Tiwi cohort and samples from
11 populations included in phase III of the HapMap Project indicated that Tiwi Islanders
are a relatively distinct and unique population with no close genetic relationships to the
other ethnic groups. After adjusting for age and sex, the proportion of ACR variance
explained by the 370K SNPs was estimated to be 37% (using the software GCTA.31;
likelihood ratio = 8.06, p-value = 0.002). The GWAS identified eight SNPs that were
nominally significantly associated with ACR (p < 0.0005). A replication study of these
SNPs was performed in an independent cohort of 497 individuals on the eight SNPs.
Four of these SNPs were significantly associated with ACR in the replication sample
(p < 0.05), rs4016189 located near the CRIM1 gene (p = 0.000751), rs443816 located
in the gene encoding UGT2B11 (p = 0.022), rs6461901 located near the NFE2L3 gene,
and rs1535656 located in the RAB14 gene. The SNP rs4016189 was still significant
after adjusting for multiple testing. A structural equation model (SEM) demonstrated
that the rs4016189 SNP was not associated with other phenotypes such as estimated
glomerular filtration rate (eGFR), diabetes, and blood pressure.
Keywords: chronic kidney disease, genome-wide association study, Australian Aboriginal and Torres Strait
Islanders, indigenous genetics, gene–environment interaction, urinary albumin creatinine ratio
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INTRODUCTION
There is an epidemic of renal disease in the Australian Aboriginal
population. In the Northern Territory (NT), diabetes deaths in
Aboriginal people are increased up to 15-fold, cardiovascular
deaths by three- to sixfold (Hoy, 1996), while rates of treated
end-stage renal disease (ESRD) are more than 20 times that
of non-Indigenous Australians overall, and more than 60-fold
greater in some regions (Spencer et al., 1998). The burden of
morbidity is great, costs of hospitalization and ESRD treatment
are huge (You et al., 2002) and premature deaths of young
and middle-aged adults have incalculable impact on families
and communities. Studies in the NT Aboriginal communities
of Nauiyu, Wadeye, Borroloola (the Outreach communities),
the Tiwi Islands, and Angurugu, showed that the rates of
hypertension, albuminuria/proteinuria, and diabetes were high,
although they differed by community (Hoy et al., 2006b).
Relative to the (mostly non-Indigenous) participants in the
nationwide AusDiab study, rates of proteinuria in the first three
of these Aboriginal communities were increased 2.3- to 8.7-fold,
hypertension was increased 2.7- to 3.6-fold and diabetes was
increased 6- to 9.6-fold (Hoy et al., 2006b). Incidence increased
markedly with age. In addition, there was pronounced overlap of
these conditions that also increased with increasing age.
The causes of this disease epidemic are poorly understood
but are very likely linked to changes associated with compressed
transition to a quasi-western lifestyle in the last 50 years.
However, smoking and obesity do not appear to fully explain
the disease (Wang and Hoy, 2003), and central fat deposition,
inflammation and infections, psychosocial stress, birthweight,
and a genetic propensity to develop renal disease in the
presence of other factors have been suggested as causes. For
example, streptococcal impetigo, and other markers of Group
A Streptococcal infection are predictive of albuminuria in
Aboriginal children and adults (Van Buynder et al., 1992;
Goodfellow et al., 1999). The same association has been seen in
this population (Hoy et al., 2012).
Renal disease in the Australian Aboriginal population has
classic pathological findings, characterized by the presence of
fewer, larger glomeruli with or without increased sclerosis (Hoy
et al., 2006a). Kidneys from Aboriginal people with no known
kidney disease have 30% fewer glomeruli (Douglas-Denton et al.,
2006; Hoy et al., 2006a) and these glomeruli tend to be larger,
as determined by autopsy. It is possible that the smaller number of
glomeruli is compensated by glomerulomegaly. Interestingly, the
most common lesion seen in biopsies from individuals with renal
disease from remote communities is glomerulomegaly and not
diabetic, or other change (Hoy et al., 2014). There is a hypothesis
that the smaller kidneys could be a consequence of low birth
weight, a variation on Barker’s hypothesis (Manalich et al., 2000;
Hoy et al., 2016). However, it is also possible that there are other
factors at play.
Kidneys with fewer, large glomeruli are termed oligomegane-
phronic kidneys. Elsewhere in the world, this condition is most
often associated with low birth weight and virtually always occurs
in infants with ESRD occurring by early childhood (Wilhelm-Bals
et al., 2014). A review of the literature (Alves et al., 2012) found
only six cases of adult-onset oligomeganephronia. Histology
on biopsies showed a pathology reminiscent of that seen in
the remote Aboriginal communities with variable presence of
glomerosclerosis (Alves et al., 2012). Mouse studies also suggest
an inverse relationship between glomerular quantity and the
presence of albuminuria (Long et al., 2013).
The Tiwi Islanders living on Bathurst and Melville Islands
north of Darwin have the one of the highest measured prevalence
of renal disease among Australian Aboriginals. The problem is
so severe that the 3000-strong islander community requires its
own dialysis unit and renal failure (start of dialysis or dying
without dialysis) is the most common cause of death. It has been
found that kidney disease is more common in Tiwi Islanders
than three other Aboriginal communities screened and nearly
10 times that of non-Aboriginal people (OR 9.7 [8.2,11.7]) (Hoy
et al., 2006b). This suggests that the Tiwi Islanders have a far
greater risk of developing renal disease than other northern
Australian Aboriginal communities, despite having a profile for
either hypertension or diabetes similar to other communities. The
Tiwi Islanders have been isolated for 15,000 years up until the
last 50–100 years (Tiwi Land Council, 2018). Consequently, we
hypothesize that genetic variants associated with kidney disease
(in the presence of other factors brought on by quasi-western
lifestyle) have become more common among the Tiwi Islanders
than mainland Aboriginals. These risk alleles could have become
more common with random drift, when the population was
genetically isolated and the environmental risks were not present.
There are over 200 genetic changes that cause or are
associated with either renal disease or renal developmental
abnormalities (Vivante and Hildebrandt, 2016). While many
of these are likely to be irrelevant to the Tiwi renal disease,
there are several genetic changes that are associated with
proteinuria alone or oligonephronia or oligomeganephronia.
These include a deletion of the short arm of chromosome 4 with
a residual monosomy known as Wolf–Hirschhorn syndrome
where oligomeganephronia is a rare accompaniment (Park and
Chi, 1993; Anderson et al., 1997). Mutations in PAX2 in both
mice and humans give rise to oligomeganephronia with the
occasional co-occurrence of a coloboma. And finally, hepatocyte
nuclear factor-1b (HNF 1b) mutations give rise to a syndrome
that includes meganephronia (Bingham et al., 2001). Current
findings suggest that the excess burden of kidney disease in
African Americans is due to risk alleles in the APOL1 gene;
however, these same risk alleles are not found in the Tiwi Islander
community (Hoy et al., 2017).
There is evidence that renal disease in Aboriginal populations
has an important genetic component. There is a significant
association between a common polymorphism at codon 72 of
the p53 gene and urine albumin creatinine ratio (ACR) among
a remote coastal Aboriginal Australian community in the East
Arnhem region of NT (McDonald et al., 2002).
The heritability of the natural log of ACR is estimated to
be 64% in an Aboriginal population, while for systolic and
diastolic blood pressure, it was only 26 and 11%, respectively. The
heritability of eGFR was not found to be significantly different
from zero (Duffy et al., 2016). This study also displayed evidence
of association of variants in ACE and TP53 with ACR.
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Here we describe a classical genome-wide association
study (GWAS) of Tiwi Islanders in which we identified
several loci associated with markers of renal disease. Two
of these loci, single nucleotide polymorphisms (SNPs)
rs443816 located in the gene encoding UGT2B11 and
rs4016189 located in the gene encoding CRIM1, were also
significantly associated with the renal disease phenotype in an
independently sampled cohort.
MATERIALS AND METHODS
Sample Collection
In the 1990s, in close consultation with the Tiwi Land Council,
the protocol was approved by the institutional ethics committee
and written informed consent was obtained from all participants.
Phenotype data were collected for 1492 samples, with sufficient
DNA obtained for 249 samples.
In 2013–2014, data were collected on a second cohort of
497 Tiwi Islander study participants. This study was carried
out in accordance with the recommendations of the Human
Ethics Committee (Tasmania) Network ethics reference number
H0012832, and in conjunction with all institutional ethics
committees of the research team and the Human Research
Ethics Committee of the NT Department of Health and
Menzies School of Health Research. Written informed consent
was obtained from all participants. Participants donated blood
and urine samples, resulting in good quality DNA samples
for 492 individuals. Clinical data collected include: date of
birth, gender, smoking and alcohol history, blood pressure or
kidney disease medicine use, height, weight, waist circumference,
random blood glucose, glycated hemoglobin, serum albumin
(measured by radioimmunoassay), serumcreatinine (measured
by jaffe reaction), estimated glomerular filtration rate (eGFR),
urinary protein, and urinary ACR. eGFR was estimated from
serum creatinine levels using the MDRD Study equation
(Levey et al., 1999).
In both cohorts, samples were collected on all participants who
presented at the clinic and consented to be a part of the study.
DNA Preparation and Analysis
The blood samples from which the DNA was derived for the
Affymetrix genotyping study were collected from Tiwi Islanders
during 1995–1996. Lymphocytes were obtained from buffy coat
preparations, and stored under liquid nitrogen. The genomic
DNA was extracted from the lymphocyte samples in 2007
using a Dneasy Blood and Tissue Kit (Qiagen). The extracted
DNA was subsequently amplified using a GenomiPhi V2 DNA
Amplification Kit V2 (GE Healthcare) to provide sufficient
quantity and quality genomic DNA for the genotyping. For
each sample, two separate 20 µL amplification reactions were
conducted, and then pooled and purified using the AMPure
PCR Purification System (Agencourt). The quantity and quality
of the amplified and purified DNA were determined using
a Nanodrop DNA Analyser (Thermo Fisher Scientific). Out
of 257 lymphocyte samples subjected to DNA extraction and
subsequent amplification, 251 met the minimum requirements
for the genotyping analysis, namely: >2µg DNA, 100 ng/µL, and
OD260/280 ratio between 1.7–1.9.
Whole genome SNP genotyping was performed on the
amplified DNA using Affymetrix 5.0 SNP chips. The accuracy
of the genotype calls was assessed by using the following
analyses. First, comparison of 25 duplicate samples indicated
a concordance rate of 98.4% (range: 96.1–99.2%). Second, we
used the genotype data to ascertain first- and second-degree
relationships among the samples (using PLINK software; Purcell
et al., 2007). These inferences were correctly predictive for 87%
of the reported relationships. Discrepancies here are likely due to
errors in self-reporting as many Tiwi Islanders are brought up by
extended families and the concept of primary carer is different
to other cultures.
The DNA used for the genotyping replication studies was
obtained from blood samples collected from Tiwi Islanders in
a separate study on the population conducted during 2015.
DNA was extracted from whole blood samples using the
Nucleospin Blood XL silica matrix system (Machery-Nagel) at
the Australian Genome Research Facility (AGRF) in Australia.
Genotyping of these samples for the SNPs identified in the
GWAS stage of the study was performed using TaqManTM
genotyping primers (Applied Biosystems). The SNP analysis
of the CRIM1 region was performed using the Sequenom
platform (by the AGRF).
Blood samples from 12 anonymous Tiwi Islanders were
sent to Illumina for whole genome sequencing in 2013, using
the HumanOmni2.5-8v1 chip. The mean fold coverage for these
samples ranged from 33.6 to 42.1. Given the small sample
size, and the lack of phenotype information, the sequence
data could not be used for association or imputation. The
sequence data could be used to identify polymorphic SNPs
for fine mapping.
Population Stratification and
Linkage Disequilibrium
A principal component analysis (PCA) was conducted using
approximately 50,000 SNPs that were polymorphic in the
Tiwi samples [minor allele frequency (MAF) > 0.2] and
that were not in linkage disequilibrium (as determined using
73 unrelated Tiwi samples and PLINK). The PCA was performed
using EIGENSOFT (Patterson et al., 2006) on samples from
11 populations in release 3 of phase III of the International
Haplotype Map Project (hapmap3) samples. The Tiwi samples
were not included in generating the principal components,
to prevent the PCs from being due to differences in platforms or
genotyping errors. The hapmap3 and the Tiwi samples were then
projected on to a plane (Figure 1) using the first two principal
components to generate a PCA plot. Eight Tiwi samples were self-
reported as being of “mixed-race” and these were indicated on
the PCA plot. The genetic distance between the midpoint of the
Tiwi samples and the 11 hapmap3 samples was calculated using
Euclidean distance including all PCs.
The median length of haplotype blocks across the genome
was estimated for each of the Tiwi samples and the 11 hapmap3
samples; the median haplotype block size was then calculated
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FIGURE 1 | Population genetic analyses of 73 unrelated individuals from the 249 Tiwi cohort from the 1990s. (A) A plot of the first two principal components (PCs)
for an analysis of the hapmap3 samples from 11 populations and the Tiwi cohort. Each point represents an individual. More distant points are more genetically
distinct. Tiwi study participants that self-reported as mixed heritage are indicated by opaque purple squares. (B) The genetic distance between the midpoints of
each of the hapmap3 samples and the Tiwi samples was calculated using all principal components. (C) The median haplotype block size of the hapmap3 samples
from 11 populations and the 1990s Tiwi cohort. Haplotypes were defined using software Haploview based on the four gamete rule; 95% confidence intervals,
estimated using bootstrap sampling, are displayed for the estimates in B and C.
across each population. The four gamete rule was used to define
a haplotype block, dictating that all pairs of SNPs within a
haplotype block exhibit less than four possible haplotypes or
gametes, showing no evidence of a historical recombination
within the haplotype block (Thorisson et al., 2005).
Association Analysis
Genetic regions of homozygosity (ROH) were inferred using
the “Runs of Homozygosity” option in the software PLINK.
Homozygosity association was carried out by searching for ROH
that were shared by study participants with high ACR. The data
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were examined to see if the high level of kidney disease could
be explained through consanguinity by seeing if there was any
correlation between log(ACR) and the total number and length
of ROH for each individual.
For the association analysis, the natural log of ACR was used,
and age and sex were included as covariates. In a previous study
from the same population, heritability of ACR was estimated
to be 64%, while the heritability of eGFR was not significantly
greater than zero (Duffy et al., 2016). Detectable reduction in
eGFR, assessed through creatinine-based measures, is a late
event in the expression of renal disease in this population
which is uniformly predicted by years of albuminuria, and once
established progresses quickly to kidney failure. Thus, it manifests
in only small numbers of people at any given study which
excludes people on dialysis, and is not such a good endo-
phenotype for kidney disease (Hoy et al., 2001).
The variance of ACR that can be explained by the Affy 5.0
genotypes was examined using the GCTA software (Yang et al.,
2011). The association analysis was conducted with a linear
mixed model, also using the software GCTA. An additive genetic
model was assumed and age was adjusted for by treating it as a
covariate. The linear mixed effects regression model accounts for
the non-independence among family members by modeling the
variance structure of the relationships between individuals as a
random effect. The analysis adjusted for relatedness by inferring
it from the genome wide data. The software GCTA is just one
of many methods for adjusting for relatedness in genome wide
studies (Thomson and McWhirter, 2017). It has the advantage
that we were able to obtain more power, by not including the
chromosome that the locus of interest was on, in the relatedness
inference (option –mlma-loco in GCTA).
To examine whether our top hit (rs4016189), which was in a
gene desert, could affect transcriptional regulation of the nearest
gene (CRIM1), we interrogated an eQTL dataset published
previously (Xia et al., 2012). This dataset contains p-values for
the association between gene expression (of all known genes) and
a genome wide set of SNPs, in 11 hapmap3 samples. From this
dataset, the p-values were extracted for association between the
SNPs within the genomic region of our top hit, and regulation of
CRIM1 in the Mexican hapmap population.
The Follow-Up Dataset
The top eight SNPs from the GWAS, were re-genotyped in the
second cohort at the AGRF. These SNPs were chosen if the
p-value of the corresponding SNP and the next closest SNP
were both less than 0.0005 [corresponding to a − log10(p-value)
greater than 3.3]. Whole genome data were not collected on all
497 Tiwi Islanders from the second cohort, so it was not possible
to adjust for relatedness. A simple linear regression model was
used to measure the significance of association for the top eight
SNPs and the fine mapping analyses. The covariate, age was
adjusted for, and an additive genetic model was assumed.
Structural Equation Model
A structural equation model (SEM) was used to examine the
genotype most associated with ACR, and its effect on other
phenotypes. SEMs provide an approach to propose a causal
hypothesis in a statistical framework that can then yield causal
interpretations conditional on the model assumptions and
data. The R package; piecewiseSEM was used to estimate the
coefficients that describe the strength of the causal pathways
in the SEM, as it allowed the use of generalized linear
models (Lefcheck, 2016). Dependent variables in the SEM
are ACR, eGFR, systolic blood pressure (sysBP), and diabetes
(HbA1c > 6.5). ACR was logged and diabetes is modeled using a
logistic regression model to match the assumptions of regression.
The SEM was modeled assuming a causal relationship from
diabetes to blood pressure and to ACR/eGFR and that ACR
and eGFR are correlated. Using the standardized coefficients, the
effect sizes of the genotype (rs4016189), age, sex, and body mass
index (BMI) on the dependent variables were compared.
RESULTS
Phenotypes
The summary statistics of kidney disease, blood pressure,
diabetes, age, and BMI are shown in Table 1 for the two cohorts.
The variance in ACR, explained by genotype as measured
by the Affymetrix 370K SNP chips was 37% (estimated using
the software GCTA), after adjusting for age and sex. This
was significantly greater than zero (likelihood ratio = 8.06,
p-value = 0.002), showing that the genetic variation in the SNPs
genotyped has a significant effect on the risk of kidney disease,
and the SNPs explained 37% of the variation in ACR among the
Tiwi Islanders. We would expect that the variance explained by
TABLE 1 | Mean/median/proportion of the variables of interest in the two cohorts
of Tiwi study participants.
1990s Cohort 2013–4 Cohort
Number of participants
with genotype data
249 497
Age (mean, range) (years) 33.3 (12–73) 39.7 (17–75)
Sex (number of
males/females)
133 M, 116 F 253 M, 239 F
ACR (median, IQR, range)
(mg/g creat)
20 (7–249) (1–6058) 23 (7–159) (1–17,555)
eGFR (mean, range)
(mls/min/1.73 m2)
105.9 (25–243) 84.4 (5–90)
Systolic BP (mean, range)
(mmHg)
121.2 (84–170) 114.5 (71–187)
Diastolic BP (mean,
range) (mmHg)
73.2 (39–122) 73.8 (48–124)
Diabetes (Y/N in 1990s
cohort∗, hba1c > 6.5 in
2013–4 cohort)
8.5% 18.2%
BMI (median and IQR) 22.3 (19–27) 23.8 (21–28)
Relationships 135 (0.5%) are first
degree relationships,
307 (1.2%) are second
degree relationships.
Unknown
∗ In the 1990s cohort, a study participant was deemed to have diabetes if a clinical
history was in the records, or if they were on hypoglycemic medications, or WHO
diagnostic levels of glycemia fasting or were 2 h after oral glucose challenge.
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the whole genome sequence data to be closer to the heritability
estimate of 64% (Duffy et al., 2016), as there are likely to be rare
variants that also contribute to variation in ACR.
Genotypes
The Affymetrix 5.0 SNP chip is made up of approximately 500,000
SNPs that are known to have a MAF > 0.05 in a Caucasian
population. Based on the 249 individuals that were part of the
1990s sample, for the Tiwi population, 40% of these SNPs have
a MAF < 0.05 and 35,000 of these SNPs are monomorphic. This
high rate of monomorphism may be because Affymetrix 5.0 SNPs
were selected to be polymorphic in a Caucasian population, while
other SNPs could be polymorphic in the Tiwi population.
We used the genome wide SNP data to conduct a PCA
to compare the Tiwi samples with several other ethnic groups
and to distinguish whether there was any evidence of popu-
lation stratification within the Tiwi samples. The PCA results
(Figures 1A,B and Supplementary Table S1) distinguish several
different ethnic groups into individual clusters, including the
African Masssai, Luhya and Yoruba people, and Mexicans. The
Han and United States-based Chinese and Japanese groups
clustered together in a separate domain, as did the Tuscans and
CEPH European ancestry groups. Strikingly, the Tiwi clustered
together in another completely separate domain of the PCA
plot. Eight Tiwi samples were self-reported as being of “mixed-
race.” Four of these were noticeably separated from the other
Tiwi samples. However, there was no evidence of population
stratification within the Tiwi samples.
The median haplotype block size of the Tiwi samples was
16.3 kb (95% C.I.: 16.1–16.5 kb), based on the four gamete rule.
When comparing this estimate to the median haplotype block
size to the other populations, LD extends further in the Tiwi
samples than the African and some other populations (Figure 1C
and Supplementary Table S1). However, LD does not extend
further than the Chinese, Japanese, or Tuscan populations,
suggesting that the Tiwi population have a distant common
ancestor, despite their small effective population size.
Association
Genetic ROH were inferred using the “Runs of Homozygosity”
option in the software PLINK. We found that there were no
runs of inferred homozygosity that were shared by more than
two individuals. The total length of inferred ROH was not
significantly longer for individuals with higher ACR (kendall’s
r = 0.018, p-value = 0.67), suggesting that higher levels
homozygosity do not explain the higher levels of kidney disease in
the Tiwi population. There were very few ROH inferred that were
less than 2 Mb in length. This may be due to the high genotyping
error rate or low coverage. Consequently, it may be possible that
the higher levels of kidney disease in the Tiwi population could
be due, in part, to shorter runs of homozygosity that are less
than 2 Mb in length.
A GWAS was carried out using GCTA analysis, adjusting
for age and sex, with log(ACR) as the phenotype. This is a
mixed effects analysis that accounts for relatedness. Figure 2A
presents all the association results as −log10(p-values) across
the genome as a Manhattan plot. A quantile-quantile plot
(Figure 2B) displays the expected vs observed p-values as points
on a scatter plot, ordered from largest to smallest. The majority of
the points on the scatterplot lie on the one-to-one line, suggesting
that the p-values are not over-inflated (as could happen with
unaccounted relatedness or population stratification). The most
significant SNPs (largest −log10 p-values) were not as significant
as expected, suggesting that the study may be underpowered,
necessitating replication.
The top eight SNPs were chosen for follow up in an
independent sample (Table 2). These SNPs were chosen when
the p-value of the corresponding SNP and the next closest SNP
were both less than 0.0005 [corresponding to a − log10(p-value)
greater than 3.3]. Among the top hits identified in the GWAS
were SNPs located in or near genes with potential roles affecting
kidney function and development. The SNP with the lowest
significance, rs4016189 (p-value = 9.76 × 10−5), was located in
a large intergenic region and approximately 614 kb upstream
of the CRIM1 gene on chromosome 2p2.22; the next closest
protein-coding gene to this SNP was more than 1 Mb distant
(in the opposite direction to CRIM1). The association between
this variant and ACR levels also remained highly significant in
the replication study (p-value = 0.000751). The associated allele
was more common in both Tiwi cohorts, than other populations
(Table 3). CRIM1 encodes Cysteine Rich Transmembrane BMP
Regulator 1, a transmembrane protein containing six cysteine-
rich repeat domains and an insulin-like growth factor-binding
domain. It is known to have roles in renal development
(Wilkinson et al., 2012; Phua et al., 2013) and mice with a
Crim1 knockdown develop a glomerulomegaly (Georgas et al.,
2000) and therefore was of high interest to our study. To test
the possibility that the SNP could be involved in transcriptional
regulation of CRIM1, we interrogated the genomic region
containing this SNP in an eQTL dataset published previously
(Xia et al., 2012). We observed a significant association between
several variants, including rs4016189, and CRIM1 expression in
the hapmap3 MEX population (Supplementary Figure S1). We
also conducted a fine scale genetic analysis of the region near
rs4016189 and the CRIM1 locus. To do this, we identified variants
spanning approximately every 2 kb within the region (using
whole genome sequences from 12 Tiwi individuals), developed
Sequenom assays for each variant and genotyped these in the
497 samples in the 2013–14 cohort. The results of the association
tests conducted for each of these SNPs (97 in total) with ACR
levels are presented in Figure 3. As well as confirming the
rs4016189 association using this independent assay, we observed
multiple SNPs in this region, including those located nearest
CRIM1 (e.g., rs2968579; 455 kb away from the gene) were also
significantly associated. This provided additional evidence that a
region upstream and near to CRIM1 was associated ACR levels.
Figure 3 also displays the LD between these 97 SNPs. Three
distinct haplotype blocks can be seen across the region, although
there is some evidence that the SNPs around rs4016189 are in LD
with the SNPs around rs2968579.
Three other SNPs, rs4438816, rs6823947, and rs12511454
associated with ACR in the GWAS were located within
the same gene, UGT2B11 on chromosome 4q13.2. The
gene encodes the enzyme UDP Glucuronosyltransferase
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FIGURE 2 | (A) A Manhattan plot displaying the –log10(p-values) for the association between the phenotype ACR and the SNPs from the Affymetrix SNP Chip.
(B) A QQ-plot, showing the observed p-values on the y-axis and the expected p-values on the x-axis under the null hypothesis of no association.
TABLE 2 | The top eight hits in the GWAS study on the original cohort, along with the association results in the replication cohort.
p-value in p-value of nearest p-value in
Position (bp) Assoc. original SNP in original replication
Chr SNP GRCh38.p12 allele Nearest gene sample sample sample
2 rs4016189 35741807 C CRIM1 (614 kbp away) 9.76E-05 0.000433 0.000751
4 rs4438816 69165940 T UGT2B11 0.000739 5.24E-05 0.022
4 rs6823947 69545677 A UGT2B11 5.24E-05 0.000294 0.079
4 rs12511454 69566288 G UGT2B11 0.000294 5.24E-05 0.078
7 rs6461901 25990123 A NFE2L3 (162 kb away) 3.70E-05 0.000173 0.035
9 rs1535656 121188709 C RAB14 0.000144 0.000145 0.037
17 rs2279057 76313344 C PRPSAP1 0.000109 0.000203 0.069
20 rs2254239 56994842 C lncRNA, LOC105372683 (8 kb away) 3.39E-05 0.000288 0.962
TABLE 3 | Allele frequencies of the associated alleles for SNPs that were significant in the replication study (p < 0.05).
Assoc Allele freq. in Allele freq. in Allele freq Allele freq. Allele freq.
Chr SNP allele Gene Tiwi Cohort 1 Tiwi Cohort 2 in MEX in YRI in CEU
2 rs4016189 C CRIM1 (614 kbp away) 0.83 0.82 0.36 0.55 0.52
4 rs4438816 T UGT2B11 0.40 0.46 0.25 0.26 0.18
7 rs6461901 A NFE2L3 (162 kb away) 0.21 0.25 0.08 0.75 0.14
9 rs1535656 C RAB14 0.27 0.24 0.26 0.01 0.10
Allele frequencies for the other populations were obtained from https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/. MEX = Mexican Ancestry in the
United States, YRI = Yoruba in Ibadan, Nigeria, CEU = North and Western European Ancestry in United States.
(UGT) Family 2 Member B11 (EC 2.4.1.17) – none of the
associated SNPs changed the coding sequence of this gene.
The former SNP was also significantly associated with ACR
in the replication study (p = 0.022), although associations
for the other two did not quite reach significance (p = 0.079
and 0.078). The associated allele for rs4438816 was more
common in both Tiwi cohorts, than other populations
(Table 3). Members of the UGT enzyme family catalyze an
intracellular process known as glucuronidation, in which
potentially toxic endogenous compounds as well as many
drugs and xenobiotics are conjugated and subsequently
eliminated from the body. Previous studies have shown that
some xenobiotics cause kidney disease, such as Balkan endemic
nephropathy (BEN) caused by exposure to aristolochic acid
present in flour produced from wheat from the endemic areas
(Stefanovic and Polenakovic, 2009).
Two additional SNPs, rs6461901 and rs1535656, were also
significantly associated with ACR levels in the replication study
(p < 0.05). The associated alleles in these two SNPs did not
consistently have higher allele frequencies in the Tiwi samples,
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FIGURE 3 | The association between ACR and 97 SNPs in the region surrounding rs4016189 is displayed as –log10 p-values. CRIM1 gene lies 448 kb upstream
of the region displayed on this graph. Positions are based on ensembl GRCh38.p12. Below the graph, the linkage disequilibrium between each of the 97 SNPs is
displayed as gray/white squares, using the four gamete rule. SNPs that do not show all four possible haplotypes/gametes (i.e., in LD) are colored gray
(as opposed to white).
compared to other populations (Table 3). The former SNP
is located in an intergenic region and approximately 162 kb
upstream of NFE2L3 on chromosome 2q31.2. NFE2L3 encodes
a transcription factor, nuclear factor erythroid 2-related factor 2
(NRF2), which has been widely studied for its cytoprotective
functions, including in kidney disease (Nezu et al., 2017). The
other SNP was located in an intronic region of RAB14 on
chromosome 9p33.2. RAB14 encodes a GTPase expressed in
many cell types, including the kidney, and is involved the
regulation of ER protein trafficking (Junutula et al., 2004).
No obvious roles in kidney function or development have been
ascribed to this gene. None of the other SNP identified in the
GWAS were significantly associated with ACR levels in the
replication study.
Associations With Other Phenotypes
A SEM was fitted to compare the effect sizes of the SNP
rs4016189, that is near CRIM1, with known risk factors
for kidney disease, blood pressure, and diabetes (Figure 4
and Supplementary Table S2). The SEM consisted of four
regression equations, explaining the variation in four dependent
variables; ACR, eGFR, sysBP, and diabetes (HbA1c > 6.5).
ACR and eGFR were negatively correlated (red curved arrow)
as expected, since high ACR and low eGFR correspond
to kidney disease.
The SEM displayed that the SNP, rs4016189 was significantly
independently associated with ACR, but not with sysBP, diabetes,
or eGFR. The effect size of this SNP on ACR was smaller than age,
BMI, and sysBP, but larger than gender.
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FIGURE 4 | Representation of a structural equation model, exploring the comorbidity of kidney disease, blood pressure, and diabetes. The boxes represent the
measures and the arrows show the relationships between the variables (black/red arrows for positive/negative relationships, respectively). The thickness of the arrows
has been scaled based on the magnitude of standardized regression coefficients for putative causative relationships (straight arrows) and correlation coefficients for
correlated variables (curved arrows). The line type of the arrow denotes significance (solid = >p-value < 0.05; dotted => p-value > 0.05). The percentage variance
explained by the risk factors is also shown in the boxes. The models also adjusted for cohort, but coefficients are not shown here to make the graphs simpler.
The largest standardized effect size in the SEM was the positive
effect of age on diabetes, followed by the negative effect of age
on eGFR. The risk factors described the largest proportion of the
variation in ACR, and the smallest variation in sysBP, suggesting
that there are other risk factors involved in sysBP.
DISCUSSION
Australian Aboriginals experience a high burden of kidney
disease that is at least partly independent of other comorbidities
that affect kidney function. The problem is particularly acute
among the Tiwi Islanders, where rates of ESKD are 30 times
that of the general Australian population. The Tiwi have lived
in relative isolation for probably thousands of years, and
anecdotally, did not suffer from renal disease prior to adopting
a quasi-Western lifestyle sometime during the mid-late 20th
century. It is possible that dietary and/or other environmental
factors introduced since this time have contributed to the
rapid emergence of the disease. However, our previous studies
indicated a significant heritable component (Duffy et al., 2016),
raising the possibility that individuals are genetically predisposed
to the disease, but only in the presence of these hypothetical
environmental risk factors, i.e., gene–environment interactions.
In this study, we investigated the genetic contribution to renal
disease in Tiwi Islanders by conducting a GWAS, in which
associations were tested between SNP genetic variants and
single measure ACR levels. A number of nominally significantly
associated SNPs were identified. These SNPs did not reach
genome wide significance, probably due to the small sample size.
The top eight SNPs were re-tested for association in a separately
collected cohort from the same population. Four of these SNPs
were significantly associated with ACR in the replication sample
(p < 0.05), and through examination of their known biology and
functions, there are possible mechanisms through which renal
disease in Tiwi Islanders may manifest.
We identified a genomic region upstream and near to the
CRIM1 locus. The prototypical GWAS SNP in this region,
rs4016189, was also significantly associated in the replication
study, as were a set of additional SNPs located between this
SNP and CRIM1. The indicative region of association spans at
least 250 kb; however, our analysis did not extend sufficiently
to include the CRIM1 locus itself. The associated region may be
involved in regulating CRIM1 transcription, as suggested by the
positive eQTL signal from the rs4016189 SNP. It is also possible
that there are other more distantly located variants that are in
linkage disequilibrium that influence gene function, although
we did not observe any non-synonymous changes in CRIM1
in the 12 genome-sequenced samples. A further in-depth study
of the interval and the relationship between sequence variation
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and CRIM1 gene expression will be required to understand
the functional link between the associated variant and disease
phenotype. The function of CRIM1 is not well understood,
but it has several important roles in development, including
in the kidney. Basic studies in the mouse demonstrate that
the murine homolog, Crim1, is expressed in the developing
kidney (Georgas et al., 2000); it is also localized in descending
loop of Henle cells in the adult kidney (Park et al., 2018).
In humans, immunohistochemical studies of have localized
CRIM1 to the podocyte slit diaphragm of the adult human
kidney (Nystrom et al., 2009). Crim1 knockout mice die in
utero from multiple organ defects. However, a subset of mice
homozygous for a Crim1 hypomorphic mutation, called KTS264
(Phua et al., 2013) survive to adulthood and go on to develop a
glomerulomegaly that is reminiscent of that seen in biopsy studies
of Australian Aboriginal renal patients. It is therefore tempting
to speculate that the renal disease associated variants modify
CRIM1 expression in such a way as to affect the developing kidney
and lead, possibly in conjunction with added environmental
factor(s), to the renal disease susceptibility phenotype in the
Tiwi. That the associated variant may operate directly through
effects on kidney function is further supported by our structural
equation modeling, which showed no relationships between the
variant and kidney disease risk factors such as diabetes and
sysBP. However, age, BMI, and blood pressure were all shown to
have a greater effect on urinary ACR than the prototypical SNP.
Therefore, the underlying causes of disease are clearly complex.
The GWAS also implicated a locus encoding a UGT,
UGT2B11, in the renal disease susceptibility. Three SNPs in this
gene were independently associated with ACR, although only
one remained significant in the replication study. The functions
of UTGs, and their known involvement in disease, indicate
their possible involvement in renal disease pathophysiology.
UGTs catalyze the conjugation of glucuronide moieties to
many drugs and xenobiotic compounds, an important step
in the Phase II detoxification pathway of drug metabolism.
Exposure to certain xenobiotics has been shown to cause
renal disease. For example, BEN which results from exposure
to aristolochic acid present in flour produced in this region
(Arsenovic´ et al., 2005) and in animals exposed to mycotoxins
(fungal toxins) in contaminated feedstock (Austwick, 1984).
Interestingly, BEN is only observed in some households
despite the ubiquitous exposure to this xenobiotic, and
both a genetic predisposition and environmental (xenobiotic)
influence have therefore been implicated. A potential role for
genetic factors influencing xenobiotic metabolism is exemplified
in a common polymorphism causing UGT2B17 deficiency.
UGT2B17 is known to conjugate testosterone and other
androgens, and thus enable their excretion in the urine. The
genetic deficiency causes dysregulation of testosterone levels
including reduced urinary excretion (Jakobsson et al., 2006).
In androgen anabolic steroid (AAS) use, urinary detection of
the drug is compromised in UGT2B17 deficient individuals
and affected abusers can develop renal function problems,
presumably because of build-up of AAS (Deshmukh et al.,
2010). Therefore, we hypothesize that the renal disease
associated UGT2B11 variant identified in the Tiwi may
compromise an ability to conjugate and thus excrete a
nephrotoxic xenobiotic or produce a nephrotoxic xenobiotic
by conjugation of pro-substance. It is also conceivable that
the introduction of this compound coincided with their
recent adoption of a Westernized life-style and changed
living conditions.
A third associated SNP, rs6461901, lies near a gene whose
product, NRF2, is a well-characterized transcriptional regulator
that directs the expression of cellular systems employed
to protect against oxidant and electrophile-induced stress.
Oxidative damage is central to organ damage following
ischemic injury, for example, and in the kidney upregulation
of NRF2 function provides protection against the development
of chronic kidney disease resulting from such injury. This
has been shown in many studied in mice with genetic
modifications affecting NRF2 function and in human
clinical trials using small molecule activators of NRF2
(reviewed in Nezu et al., 2017). We therefore speculate
that altered NRF2 expression or function could affect the
severity of renal disease in the Tiwi, although we have no
knowledge of how the associated variant may affect the
gene or its product.
The Tiwi people have been proactively engaged with research
in their community for 30 years or more. In the 1980s, research
was seen as exploitative by many Indigenous leaders; at that
time when there was no national leadership to provide ethical
guidance for researchers and support for communities (Kowal
and Anderson, 2012). The Tiwi people worked with the Menzies
School of Health Research from its earliest years; Menzies had
established an ethics committee with Indigenous members to
oversight its research. Subsequently, the Tiwi Land Council,
through its Health Board, signed an historic research agreement
with Menzies to formalize Tiwi control of the research priorities,
research information, and samples. This is believed to have
been the first ever such legal agreement between an Indigenous
community and a research organization.
The Menzies School of Health Research had also helped to
focus the national debate by organizing the 1986 conference
in Alice Springs, attended by Indigenous leaders, researchers,
and NHMRC representatives; this helped to launch a process
that eventually led to NHMRC research guidelines to support
community decision-making and control of Indigenous
health research.
The Tiwi people’s engagement with research has had a parti-
cular emphasis on chronic disease and kidney disease. They
have articulated and shaped the research directions, raised
local financial support and raised external funds, specifically
the Stanley Tipiloura Fund (to honor the first Tiwi MLA) to
support the first phases of this research, worked with government
agencies, including Australia’s National Health and Medical
Research Council, with Kidney Health Australia (and through
them, Rio Tinto), and with Servier, Australia. Tiwi people have
worked as staff and leaders in all the research projects conducted
within their community, and Tiwi people have participated in
many surveys, treatment programs, and controlled clinical trials.
Tiwi people pioneered governance of research processes with
formation of the Tiwi Health Board, founded their own Scientific
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Research and Advisory Group and Committee. Tiwi advocated
for and house the first satellite dialysis unit in the NT. Tiwi people
encouraged application of genetics research, to illuminate their
origins, migrations, customs, relationships, and health issues, and
they are proud to be contributors on the world stage.
We also investigated the relative degree of genetic relatedness
between the Tiwi and other populations using PCA and
a set of polymorphic SNPs identified in the Tiwi GWAS
study. We observed that the Tiwi samples clustered in
a single group, that was well-separated and distant from
all of the other populations tested. As an example of
the relative genetic differences observed, the approximate
genetic distance separating the closest population to the
Tiwi, Mexicans, was similar to that separating Mexicans from
Europeans. Collectively, the analysis is strongly suggestive
of the Tiwi’s long existence as a genetically distinct and
isolated population. These data have been discussed with
members of the Tiwi Land Council and has elicited a large
degree of interest, as it is pertinent to the story of the
origins of the Tiwi.
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